Alzheimer's disease: insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/China

With the ageing of the global population, China is projected to be impacted significantly by the rising number of patients with Alzheimer's disease (AD). A cure for AD is not yet available, so society should be prepared for an increasing AD-related burden. In this review, we examine this impend...

Full description

Saved in:
Bibliographic Details
Published in:Hong Kong medical journal = Xianggang yi xue za zhi 2018-10, Vol.24 (5), p.492-500
Main Authors: Yee, A, Tsui, N By, Chang, Y N, Au, C Sm, Fok, M, Lau, L T, Chung, T, Chung, G, Kwan, R Yc, Leung, A Ym, Lau, J Yn, Dai, D Lk
Format: Article
Language:English
Subjects:
Age
Aged
Alzheimer Disease - epidemiology
Alzheimer Disease - etiology
Alzheimer Disease - prevention & control
Alzheimer's disease
Asian Continental Ancestry Group
Asymptomatic
Atrophy
China - epidemiology
Cognitive ability
Dementia
Early Diagnosis
Female
Genomes
Health Services for the Aged
Hong Kong - epidemiology
Humans
Incidence
Male
Memory
Middle Aged
Older people
Peptides
Prevalence
Risk Factors
White people
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c354t-1be5b56c332d69a82c76f9318d5293ebd334fa14f81deff983ab8e05fa10f7e63
cites
container_end_page 500
container_issue 5
container_start_page 492
container_title Hong Kong medical journal = Xianggang yi xue za zhi
container_volume 24
creator Yee, A
Tsui, N By
Chang, Y N
Au, C Sm
Fok, M
Lau, L T
Chung, T
Chung, G
Kwan, R Yc
Leung, A Ym
Lau, J Yn
Dai, D Lk
description With the ageing of the global population, China is projected to be impacted significantly by the rising number of patients with Alzheimer's disease (AD). A cure for AD is not yet available, so society should be prepared for an increasing AD-related burden. In this review, we examine this impending problem and provide overviews on (a) the magnitude of the problem of AD in Hong Kong/China in the near future; (b) the genetic and lifestyle risk factors that contribute to AD; (c) current diagnostic approaches and the potential of newly discovered genetic biomarkers for early detection; (d) medications, non-pharmacological interventions, and possible preventive measures; and (e) the need for social and psychological care from the community. In Hong Kong, primary care and AD-related support for at-risk individuals, patients, and caregivers are inadequate. A joint effort from the medical community, government, universities, non-governmental organisations/charities, and industry should initiate the development of a long-term programme for AD. Finally, we outline recommendations for the relevant parties to consider.
doi_str_mv 10.12809/hkmj187244
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2120743299</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2120743299</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-1be5b56c332d69a82c76f9318d5293ebd334fa14f81deff983ab8e05fa10f7e63</originalsourceid><addsrcrecordid>eNpdkcFO3DAURa2qqAzQVfeVpS5AqlLs5yR22KERLQikbug6cpLniYfEntrJSPAl_dx6BgpSN8969vHRlS4hnzj7xkGx6rx_GNdcScjzd2QBAGWmJJPvyYIzyDOQTB2SoxjXjIEqKvaBHAoGInFyQf5cDk892hHDaaSdjagjXlDrol31U6TGBxpsfKC41cOsJ-sd1a6jm4BbdPvVOjr1SJe9dRiRbvxmHt7A3ZND7PYmTVs_pq89Jv82scGvgh5H3EmuvVvR2zTOdyp9Qg6MHiJ-fDmPya_vV_fL6-zu54-b5eVd1ooinzLeYNEUZSsEdGWlFbSyNJXgqiugEth0QuRG89wo3qExlRK6UciKdMeMxFIck7Nnbwrze8Y41aONLQ6DdujnWAMHJnMBVZXQL_-haz8Hl9LVIFUJJRNyR319ptrgYwxo6k2wow6PNWf1vrD6rbBEf35xzs2I3Sv7ryHxF6okkzU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2786260379</pqid></control><display><type>article</type><title>Alzheimer's disease: insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/China</title><source>Publicly Available Content Database</source><creator>Yee, A ; Tsui, N By ; Chang, Y N ; Au, C Sm ; Fok, M ; Lau, L T ; Chung, T ; Chung, G ; Kwan, R Yc ; Leung, A Ym ; Lau, J Yn ; Dai, D Lk</creator><creatorcontrib>Yee, A ; Tsui, N By ; Chang, Y N ; Au, C Sm ; Fok, M ; Lau, L T ; Chung, T ; Chung, G ; Kwan, R Yc ; Leung, A Ym ; Lau, J Yn ; Dai, D Lk ; Avalon Genomics (HK) Limited, Shatin, Hong Kong</creatorcontrib><description>With the ageing of the global population, China is projected to be impacted significantly by the rising number of patients with Alzheimer's disease (AD). A cure for AD is not yet available, so society should be prepared for an increasing AD-related burden. In this review, we examine this impending problem and provide overviews on (a) the magnitude of the problem of AD in Hong Kong/China in the near future; (b) the genetic and lifestyle risk factors that contribute to AD; (c) current diagnostic approaches and the potential of newly discovered genetic biomarkers for early detection; (d) medications, non-pharmacological interventions, and possible preventive measures; and (e) the need for social and psychological care from the community. In Hong Kong, primary care and AD-related support for at-risk individuals, patients, and caregivers are inadequate. A joint effort from the medical community, government, universities, non-governmental organisations/charities, and industry should initiate the development of a long-term programme for AD. Finally, we outline recommendations for the relevant parties to consider.</description><identifier>ISSN: 1024-2708</identifier><identifier>EISSN: 2226-8707</identifier><identifier>DOI: 10.12809/hkmj187244</identifier><identifier>PMID: 30232267</identifier><language>eng</language><publisher>China: Hong Kong Academy of Medicine</publisher><subject>Age ; Aged ; Alzheimer Disease - epidemiology ; Alzheimer Disease - etiology ; Alzheimer Disease - prevention &amp; control ; Alzheimer's disease ; Asian Continental Ancestry Group ; Asymptomatic ; Atrophy ; China - epidemiology ; Cognitive ability ; Dementia ; Early Diagnosis ; Female ; Genomes ; Health Services for the Aged ; Hong Kong - epidemiology ; Humans ; Incidence ; Male ; Memory ; Middle Aged ; Older people ; Peptides ; Prevalence ; Risk Factors ; White people</subject><ispartof>Hong Kong medical journal = Xianggang yi xue za zhi, 2018-10, Vol.24 (5), p.492-500</ispartof><rights>2018. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c354t-1be5b56c332d69a82c76f9318d5293ebd334fa14f81deff983ab8e05fa10f7e63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2786260379/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2786260379?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>315,783,787,25765,27936,27937,37024,37025,44602,75460</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30232267$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yee, A</creatorcontrib><creatorcontrib>Tsui, N By</creatorcontrib><creatorcontrib>Chang, Y N</creatorcontrib><creatorcontrib>Au, C Sm</creatorcontrib><creatorcontrib>Fok, M</creatorcontrib><creatorcontrib>Lau, L T</creatorcontrib><creatorcontrib>Chung, T</creatorcontrib><creatorcontrib>Chung, G</creatorcontrib><creatorcontrib>Kwan, R Yc</creatorcontrib><creatorcontrib>Leung, A Ym</creatorcontrib><creatorcontrib>Lau, J Yn</creatorcontrib><creatorcontrib>Dai, D Lk</creatorcontrib><creatorcontrib>Avalon Genomics (HK) Limited, Shatin, Hong Kong</creatorcontrib><title>Alzheimer's disease: insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/China</title><title>Hong Kong medical journal = Xianggang yi xue za zhi</title><addtitle>Hong Kong Med J</addtitle><description>With the ageing of the global population, China is projected to be impacted significantly by the rising number of patients with Alzheimer's disease (AD). A cure for AD is not yet available, so society should be prepared for an increasing AD-related burden. In this review, we examine this impending problem and provide overviews on (a) the magnitude of the problem of AD in Hong Kong/China in the near future; (b) the genetic and lifestyle risk factors that contribute to AD; (c) current diagnostic approaches and the potential of newly discovered genetic biomarkers for early detection; (d) medications, non-pharmacological interventions, and possible preventive measures; and (e) the need for social and psychological care from the community. In Hong Kong, primary care and AD-related support for at-risk individuals, patients, and caregivers are inadequate. A joint effort from the medical community, government, universities, non-governmental organisations/charities, and industry should initiate the development of a long-term programme for AD. Finally, we outline recommendations for the relevant parties to consider.</description><subject>Age</subject><subject>Aged</subject><subject>Alzheimer Disease - epidemiology</subject><subject>Alzheimer Disease - etiology</subject><subject>Alzheimer Disease - prevention &amp; control</subject><subject>Alzheimer's disease</subject><subject>Asian Continental Ancestry Group</subject><subject>Asymptomatic</subject><subject>Atrophy</subject><subject>China - epidemiology</subject><subject>Cognitive ability</subject><subject>Dementia</subject><subject>Early Diagnosis</subject><subject>Female</subject><subject>Genomes</subject><subject>Health Services for the Aged</subject><subject>Hong Kong - epidemiology</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Memory</subject><subject>Middle Aged</subject><subject>Older people</subject><subject>Peptides</subject><subject>Prevalence</subject><subject>Risk Factors</subject><subject>White people</subject><issn>1024-2708</issn><issn>2226-8707</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkcFO3DAURa2qqAzQVfeVpS5AqlLs5yR22KERLQikbug6cpLniYfEntrJSPAl_dx6BgpSN8969vHRlS4hnzj7xkGx6rx_GNdcScjzd2QBAGWmJJPvyYIzyDOQTB2SoxjXjIEqKvaBHAoGInFyQf5cDk892hHDaaSdjagjXlDrol31U6TGBxpsfKC41cOsJ-sd1a6jm4BbdPvVOjr1SJe9dRiRbvxmHt7A3ZND7PYmTVs_pq89Jv82scGvgh5H3EmuvVvR2zTOdyp9Qg6MHiJ-fDmPya_vV_fL6-zu54-b5eVd1ooinzLeYNEUZSsEdGWlFbSyNJXgqiugEth0QuRG89wo3qExlRK6UciKdMeMxFIck7Nnbwrze8Y41aONLQ6DdujnWAMHJnMBVZXQL_-haz8Hl9LVIFUJJRNyR319ptrgYwxo6k2wow6PNWf1vrD6rbBEf35xzs2I3Sv7ryHxF6okkzU</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Yee, A</creator><creator>Tsui, N By</creator><creator>Chang, Y N</creator><creator>Au, C Sm</creator><creator>Fok, M</creator><creator>Lau, L T</creator><creator>Chung, T</creator><creator>Chung, G</creator><creator>Kwan, R Yc</creator><creator>Leung, A Ym</creator><creator>Lau, J Yn</creator><creator>Dai, D Lk</creator><general>Hong Kong Academy of Medicine</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BVBZV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20181001</creationdate><title>Alzheimer's disease: insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/China</title><author>Yee, A ; Tsui, N By ; Chang, Y N ; Au, C Sm ; Fok, M ; Lau, L T ; Chung, T ; Chung, G ; Kwan, R Yc ; Leung, A Ym ; Lau, J Yn ; Dai, D Lk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-1be5b56c332d69a82c76f9318d5293ebd334fa14f81deff983ab8e05fa10f7e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Age</topic><topic>Aged</topic><topic>Alzheimer Disease - epidemiology</topic><topic>Alzheimer Disease - etiology</topic><topic>Alzheimer Disease - prevention &amp; control</topic><topic>Alzheimer's disease</topic><topic>Asian Continental Ancestry Group</topic><topic>Asymptomatic</topic><topic>Atrophy</topic><topic>China - epidemiology</topic><topic>Cognitive ability</topic><topic>Dementia</topic><topic>Early Diagnosis</topic><topic>Female</topic><topic>Genomes</topic><topic>Health Services for the Aged</topic><topic>Hong Kong - epidemiology</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Memory</topic><topic>Middle Aged</topic><topic>Older people</topic><topic>Peptides</topic><topic>Prevalence</topic><topic>Risk Factors</topic><topic>White people</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yee, A</creatorcontrib><creatorcontrib>Tsui, N By</creatorcontrib><creatorcontrib>Chang, Y N</creatorcontrib><creatorcontrib>Au, C Sm</creatorcontrib><creatorcontrib>Fok, M</creatorcontrib><creatorcontrib>Lau, L T</creatorcontrib><creatorcontrib>Chung, T</creatorcontrib><creatorcontrib>Chung, G</creatorcontrib><creatorcontrib>Kwan, R Yc</creatorcontrib><creatorcontrib>Leung, A Ym</creatorcontrib><creatorcontrib>Lau, J Yn</creatorcontrib><creatorcontrib>Dai, D Lk</creatorcontrib><creatorcontrib>Avalon Genomics (HK) Limited, Shatin, Hong Kong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>East &amp; South Asia Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Hong Kong medical journal = Xianggang yi xue za zhi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yee, A</au><au>Tsui, N By</au><au>Chang, Y N</au><au>Au, C Sm</au><au>Fok, M</au><au>Lau, L T</au><au>Chung, T</au><au>Chung, G</au><au>Kwan, R Yc</au><au>Leung, A Ym</au><au>Lau, J Yn</au><au>Dai, D Lk</au><aucorp>Avalon Genomics (HK) Limited, Shatin, Hong Kong</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alzheimer's disease: insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/China</atitle><jtitle>Hong Kong medical journal = Xianggang yi xue za zhi</jtitle><addtitle>Hong Kong Med J</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>24</volume><issue>5</issue><spage>492</spage><epage>500</epage><pages>492-500</pages><issn>1024-2708</issn><eissn>2226-8707</eissn><abstract>With the ageing of the global population, China is projected to be impacted significantly by the rising number of patients with Alzheimer's disease (AD). A cure for AD is not yet available, so society should be prepared for an increasing AD-related burden. In this review, we examine this impending problem and provide overviews on (a) the magnitude of the problem of AD in Hong Kong/China in the near future; (b) the genetic and lifestyle risk factors that contribute to AD; (c) current diagnostic approaches and the potential of newly discovered genetic biomarkers for early detection; (d) medications, non-pharmacological interventions, and possible preventive measures; and (e) the need for social and psychological care from the community. In Hong Kong, primary care and AD-related support for at-risk individuals, patients, and caregivers are inadequate. A joint effort from the medical community, government, universities, non-governmental organisations/charities, and industry should initiate the development of a long-term programme for AD. Finally, we outline recommendations for the relevant parties to consider.</abstract><cop>China</cop><pub>Hong Kong Academy of Medicine</pub><pmid>30232267</pmid><doi>10.12809/hkmj187244</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1024-2708
ispartof Hong Kong medical journal = Xianggang yi xue za zhi, 2018-10, Vol.24 (5), p.492-500
issn 1024-2708
2226-8707
language eng
recordid cdi_proquest_miscellaneous_2120743299
source Publicly Available Content Database
subjects Age
Aged
Alzheimer Disease - epidemiology
Alzheimer Disease - etiology
Alzheimer Disease - prevention & control
Alzheimer's disease
Asian Continental Ancestry Group
Asymptomatic
Atrophy
China - epidemiology
Cognitive ability
Dementia
Early Diagnosis
Female
Genomes
Health Services for the Aged
Hong Kong - epidemiology
Humans
Incidence
Male
Memory
Middle Aged
Older people
Peptides
Prevalence
Risk Factors
White people
title Alzheimer's disease: insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/China
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-12T04%3A25%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alzheimer's%20disease:%20insights%20for%20risk%20evaluation%20and%20prevention%20in%20the%20Chinese%20population%20and%20the%20need%20for%20a%20comprehensive%20programme%20in%20Hong%20Kong/China&rft.jtitle=Hong%20Kong%20medical%20journal%20=%20Xianggang%20yi%20xue%20za%20zhi&rft.au=Yee,%20A&rft.aucorp=Avalon%20Genomics%20(HK)%20Limited,%20Shatin,%20Hong%20Kong&rft.date=2018-10-01&rft.volume=24&rft.issue=5&rft.spage=492&rft.epage=500&rft.pages=492-500&rft.issn=1024-2708&rft.eissn=2226-8707&rft_id=info:doi/10.12809/hkmj187244&rft_dat=%3Cproquest_cross%3E2120743299%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c354t-1be5b56c332d69a82c76f9318d5293ebd334fa14f81deff983ab8e05fa10f7e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2786260379&rft_id=info:pmid/30232267&rfr_iscdi=true